Our Experience at the Service of your Clinical Data.
We will support you in every step during clinical drug development at the asset, indication, or protocol level
Our Quantitative, Qualified & Quality-focused Scientists will provide solutions to help and support Pharmaceutical companies, Biotechs, MedTechs & CROs developing their product until regulatory approval & access to patient
Oncology, Immuno-oncology, Immunology, Metabolics, Cardiovascular and Neuroscience.
Phase II, III and IV.
Statistical expertise in numerous global regulatory submissions, (FDA, EMA, PMDA...), including Face to Face meetings.
HTA & Publications
Statistical support for submissions to several HTAs (AMNOG, HAS, NICE), reimbursement dossiers and scientific publications (NEJM, The Lancet, JCO ...)
Biostatistics and Data Science Consultancy.
Statistical Support at the Asset level.
Statistical Support at the Protocol Level.
The 3 co-owners have over 60 years of combined experience in the Pharma industry.
Contact us for a personalized meeting
We bring our expertise in Quantitative Sciences to your drug development project.
Each team member comes with over 15 years of experience in the pharma industry.
We are committed to become trusted partner who designs and delivers high quality solutions.